FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100051910> ?p ?o ?g. }

• W2100051910 endingPage "2702" @default.
• W2100051910 startingPage "2695" @default.
• W2100051910 abstract "Abstract Purpose: To quantify the effectiveness of anti-VEGF antibodies (bevacizumab and B20-4.1.1) as mitigators of radiation-induced, central nervous system (brain) necrosis in a mouse model. Experimental Design: Cohorts of mice were irradiated with single-fraction 50- or 60-Gy doses of radiation targeted to the left hemisphere (brain) using the Leksell Perfexion Gamma Knife. The onset and progression of radiation necrosis were monitored longitudinally by in vivo, small-animal MRI, beginning 4 weeks after irradiation. MRI-derived necrotic volumes for antibody (Ab)-treated and untreated mice were compared. MRI results were supported by correlative histology. Results: Hematoxylin and eosin–stained sections of brains from irradiated, non–Ab-treated mice confirmed profound tissue damage, including regions of fibrinoid vascular necrosis, vascular telangiectasia, hemorrhage, loss of neurons, and edema. Treatment with the murine anti-VEGF antibody B20-4.1.1 mitigated radiation-induced changes in an extraordinary, highly statistically significant manner. The development of radiation necrosis in mice under treatment with bevacizumab (a humanized anti-VEGF antibody) was intermediate between that for B20-4.1.1–treated and non–Ab-treated animals. MRI findings were validated by histologic assessment, which confirmed that anti-VEGF antibody treatment dramatically reduced late-onset necrosis in irradiated brain. Conclusions: The single-hemispheric irradiation mouse model, with longitudinal MRI monitoring, provides a powerful platform for studying the onset and progression of radiation necrosis and for developing and testing new therapies. The observation that anti-VEGF antibodies are effective mitigants of necrosis in our mouse model will enable a wide variety of studies aimed at dose optimization and timing and mechanism of action with direct relevance to ongoing clinical trials of bevacizumab as a treatment for radiation necrosis. Clin Cancer Res; 20(10); 2695–702. ©2014 AACR." @default.
• W2100051910 created "2016-06-24" @default.
• W2100051910 creator A5008096514 @default.
• W2100051910 creator A5008423688 @default.
• W2100051910 creator A5008654358 @default.
• W2100051910 creator A5010297641 @default.
• W2100051910 creator A5011661289 @default.
• W2100051910 creator A5017653267 @default.
• W2100051910 creator A5035783693 @default.
• W2100051910 creator A5056508268 @default.
• W2100051910 creator A5068762427 @default.
• W2100051910 creator A5077021350 @default.
• W2100051910 creator A5080500548 @default.
• W2100051910 date "2014-05-14" @default.
• W2100051910 modified "2023-10-14" @default.
• W2100051910 title "Anti-VEGF Antibodies Mitigate the Development of Radiation Necrosis in Mouse Brain" @default.
• W2100051910 cites W1539571840 @default.
• W2100051910 cites W1939186328 @default.
• W2100051910 cites W1971611901 @default.
• W2100051910 cites W1975276783 @default.
• W2100051910 cites W1982841952 @default.
• W2100051910 cites W2001343980 @default.
• W2100051910 cites W2006202974 @default.
• W2100051910 cites W2013436479 @default.
• W2100051910 cites W2025262976 @default.
• W2100051910 cites W2039855744 @default.
• W2100051910 cites W2041533859 @default.
• W2100051910 cites W2041946632 @default.
• W2100051910 cites W2046681082 @default.
• W2100051910 cites W2070412580 @default.
• W2100051910 cites W2070580351 @default.
• W2100051910 cites W2072494626 @default.
• W2100051910 cites W2073124329 @default.
• W2100051910 cites W2081633887 @default.
• W2100051910 cites W2082246284 @default.
• W2100051910 cites W2096287682 @default.
• W2100051910 cites W2119430710 @default.
• W2100051910 cites W2122010571 @default.
• W2100051910 cites W2127979696 @default.
• W2100051910 cites W2131480590 @default.
• W2100051910 cites W2134576194 @default.
• W2100051910 cites W2136963436 @default.
• W2100051910 cites W2137582962 @default.
• W2100051910 cites W2145566175 @default.
• W2100051910 cites W2151886675 @default.
• W2100051910 cites W2158681922 @default.
• W2100051910 cites W2166534891 @default.
• W2100051910 cites W2169262852 @default.
• W2100051910 cites W2322458195 @default.
• W2100051910 doi "https://doi.org/10.1158/1078-0432.ccr-13-1941" @default.
• W2100051910 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4135174" @default.
• W2100051910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24647570" @default.
• W2100051910 hasPublicationYear "2014" @default.
• W2100051910 type Work @default.
• W2100051910 sameAs 2100051910 @default.
• W2100051910 citedByCount "64" @default.
• W2100051910 countsByYear W21000519102013 @default.
• W2100051910 countsByYear W21000519102014 @default.
• W2100051910 countsByYear W21000519102015 @default.
• W2100051910 countsByYear W21000519102016 @default.
• W2100051910 countsByYear W21000519102017 @default.
• W2100051910 countsByYear W21000519102018 @default.
• W2100051910 countsByYear W21000519102019 @default.
• W2100051910 countsByYear W21000519102020 @default.
• W2100051910 countsByYear W21000519102021 @default.
• W2100051910 countsByYear W21000519102022 @default.
• W2100051910 countsByYear W21000519102023 @default.
• W2100051910 crossrefType "journal-article" @default.
• W2100051910 hasAuthorship W2100051910A5008096514 @default.
• W2100051910 hasAuthorship W2100051910A5008423688 @default.
• W2100051910 hasAuthorship W2100051910A5008654358 @default.
• W2100051910 hasAuthorship W2100051910A5010297641 @default.
• W2100051910 hasAuthorship W2100051910A5011661289 @default.
• W2100051910 hasAuthorship W2100051910A5017653267 @default.
• W2100051910 hasAuthorship W2100051910A5035783693 @default.
• W2100051910 hasAuthorship W2100051910A5056508268 @default.
• W2100051910 hasAuthorship W2100051910A5068762427 @default.
• W2100051910 hasAuthorship W2100051910A5077021350 @default.
• W2100051910 hasAuthorship W2100051910A5080500548 @default.
• W2100051910 hasBestOaLocation W21000519101 @default.
• W2100051910 hasConcept C126322002 @default.
• W2100051910 hasConcept C142724271 @default.
• W2100051910 hasConcept C159654299 @default.
• W2100051910 hasConcept C203014093 @default.
• W2100051910 hasConcept C2776015282 @default.
• W2100051910 hasConcept C2779134260 @default.
• W2100051910 hasConcept C2780886150 @default.
• W2100051910 hasConcept C2781082648 @default.
• W2100051910 hasConcept C503630168 @default.
• W2100051910 hasConcept C71924100 @default.
• W2100051910 hasConceptScore W2100051910C126322002 @default.
• W2100051910 hasConceptScore W2100051910C142724271 @default.
• W2100051910 hasConceptScore W2100051910C159654299 @default.
• W2100051910 hasConceptScore W2100051910C203014093 @default.
• W2100051910 hasConceptScore W2100051910C2776015282 @default.
• W2100051910 hasConceptScore W2100051910C2779134260 @default.
• W2100051910 hasConceptScore W2100051910C2780886150 @default.
• W2100051910 hasConceptScore W2100051910C2781082648 @default.

• next